CG Oncology (CGON) Enterprise Value: 5.512B

CG Oncology, Inc. (CGON)

72.59 -0.05 (-0.07%) USD | NASDAQ | Nov 11, 16:00

72.59 0.00 (0.00%) After-Hours: 19:14

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2024. Start Trial.

Date	Value
November 10, 2026	5.512B
November 09, 2026	5.699B
November 06, 2026	5.811B
November 05, 2026	4.811B
November 04, 2026	5.071B
November 03, 2026	4.745B
November 02, 2026	4.558B
October 30, 2026	4.801B
October 29, 2026	4.693B
October 28, 2026	4.736B
October 27, 2026	4.645B
October 26, 2026	4.522B
October 23, 2026	4.536B
October 22, 2026	4.610B
October 21, 2026	4.583B
October 20, 2026	4.555B
October 19, 2026	4.379B
October 16, 2026	4.369B
October 15, 2026	4.549B
October 14, 2026	4.547B
October 13, 2026	4.597B
October 12, 2026	4.662B
October 09, 2026	4.724B
October 08, 2026	4.674B
October 07, 2026	4.595B

Date	Value
October 06, 2026	4.708B
October 05, 2026	5.161B
October 02, 2026	5.042B
October 01, 2026	5.128B
September 30, 2026	5.355B
September 29, 2026	5.208B
September 28, 2026	5.128B
September 25, 2026	4.910B
September 24, 2026	5.052B
September 23, 2026	5.459B
September 22, 2026	5.845B
September 21, 2026	5.891B
September 18, 2026	5.570B
September 17, 2026	5.658B
September 16, 2026	5.526B
September 15, 2026	5.387B
September 14, 2026	5.497B
September 11, 2026	5.370B
September 10, 2026	5.339B
September 09, 2026	5.335B
September 08, 2026	5.462B
September 04, 2026	5.574B
September 03, 2026	5.544B
September 02, 2026	5.567B
September 01, 2026	5.679B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks